Our vaccine strategy and its benefits
Following the outbreak of the corona epidemic, our scientists were able to quickly begin development of a new vaccine against SARS-CoV-2 thanks to their specialized knowledge of mRNA and bioconjugation methods. Baseclick’s proprietary technologies allow targeting agents to be directly linked to mRNA sequences, thus avoiding the need for lipid nano particle formulation. In this video we explain our vaccine strategy and its benefits.
